Why the Up-C Structure Is a Good Alternative Route to an IPO
The umbrella partnership C corporation (Up-C) structure has been a popular option for pass-through entities looking to gain access to the capital markets.
Navigating SEC Comment Letters: Non-GAAP Disclosures and Metrics
Inevitably, companies looking to go public will face the prospect of comment letters from the Securities and Exchange Commission (SEC).
The Ultimate Guide to a Life Sciences IPO
The life sciences industry is in the middle of an IPO boom, with the 10 highest-valued biotech IPOs raising $3.
Meet Kelly Provost: A Leader in CFGI’s Life Sciences Capital Markets
Kelly Provost is a leader in CFGI’s Life Sciences Capital Markets practice and has dedicated her career to supporting companies that are trying to cure diseases and save lives, making a difference in the lives of people across the world.
April Coleman: Former SEC Reviewer Spearheading CFGI’s Dedicated IPO Team
Experience is as good as gold in the accounting advisory world, and arguably no one at CFGI has spent as much time working both sides of the advisory/client aisle than Partner April Coleman.
Capital Markets Advisory: 2020 Year in Review
Despite the impact of the pandemic, 2020 was a record year for the U.
SPAC Mergers Are a Popular (and Accelerated)
Way to Go Public
In the first two quarters of 2020, special purpose acquisition companies (SPACs) raised more than $30 billion, according to SPAC Research, a major increase versus the $13 billion raised in the entirety of 2019.
How to Mitigate the Cheap Stock Issue When Preparing for an IPO
When a company embarks on an initial public offering (IPO), one of the most significant challenges in the registration process with the U.